Patient satisfaction is measured through short post-visit and periodic check-in surveys completed by patients and/or caregivers. Responses are compiled across the measurement period and reported as the percent of respondents who selected “Satisfied” or “Very Satisfied.” Feedback is reviewed by our leadership team to improve scheduling, education, and consistency of in-home care.
Time to first visit is calculated as the number of calendar days from receipt of a complete referral (required demographics, clinical indication, and payer information) to the first completed in-home evaluation/visit. We track this across all new-start patients during the measurement window and monitor delays separately (referral completeness, authorization timing, patient scheduling barriers).
Symptom improvement is measured using standardized patient-reported check-ins collected at intake and follow-up, focusing on swelling, heaviness/tightness, discomfort, and functional mobility (walking tolerance, stairs, and daily activities). The reported percentage reflects patients who indicated improvement compared to their baseline during the measurement period.
We track avoidable escalations of care associated with chronic edema and lymphatic disease—especially episodes driven by cellulitis risk, skin breakdown, and uncontrolled swelling. Rates are trended over time for enrolled patients using available utilization notifications and documented clinical events. When additional data feeds are available, results are validated against partner-provided utilization reporting.
We monitor skin integrity at every visit and document changes such as new breakdown, worsening drainage, signs of infection risk, and need for escalation to the referring provider. Complication rates are tracked as documented clinical events over time for the enrolled population. This is paired with adherence to compression, skin care routines, and early identification workflows that reduce preventable deterioration.
Admissions are tracked during active enrollment using documented patient/caregiver reports, provider updates, and care coordination records. When available, partner utilization reporting is used to validate trends. The reported change reflects admissions during the measurement window, with focus on edema-driven triggers (infection risk, skin breakdown, uncontrolled swelling).
Cancellation rate is measured as cancelled or no-show visits divided by total scheduled visits over the same period. We track patient-initiated cancellations separately from clinical holds (e.g., hospitalization) and weather/force majeure. This helps us improve engagement, scheduling reliability, and adherence.
We track inpatient and observation episodes for enrolled patients and trend changes over time, with attention to edema-driven complications (skin breakdown, infection risk, uncontrolled swelling). Events are captured through available utilization notifications and documented care coordination outreach. When partner utilization reporting is available, we reconcile and validate trends.
We track inpatient and observation episodes for enrolled patients and trend changes over time, with attention to edema-driven complications (skin breakdown, infection risk, uncontrolled swelling). Events are captured through available utilization notifications and documented care coordination outreach. When partner utilization reporting is available, we reconcile and validate trends.
We track the completion of key coordination actions during the episode of care—risk factor screening, education delivered, care barriers identified, and closed-loop communication back to the care team. Coordination performance is measured through documentation completion and the timeliness of clinical updates. The goal is simple: better visibility, faster escalation when needed, and fewer gaps between the home and the medical team.